Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)

China flag China · Delayed Price · Currency is CNY
16.05
+0.26 (1.65%)
At close: Mar 10, 2026
66.32%
Market Cap 5.38B
Revenue (ttm) 1.19B
Net Income (ttm) -51.99M
Shares Out 334.89M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend 0.15 (0.95%)
Ex-Dividend Date May 30, 2025
Volume 7,790,462
Average Volume 10,419,477
Open 15.82
Previous Close 15.79
Day's Range 15.60 - 16.08
52-Week Range 9.50 - 19.56
Beta 0.34
RSI 59.71
Earnings Date Apr 29, 2026

About SHE:002923

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, quality research, and registration of chemical drugs. In addition, it provides branding services of drug products, as well as academic services. The comp... [Read more]

Sector Healthcare
Founded 1999
Employees 1,985
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002923
Full Company Profile

Financial Performance

In 2024, SHE:002923's revenue was 1.18 billion, a decrease of -8.48% compared to the previous year's 1.29 billion. Earnings were 39.88 million, a decrease of -40.38%.

Financial Statements

News

There is no news available yet.